Hande Kızılocak
9PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Aug 09, 2023
Effects of PK-guided prophylaxis on clinical outcomes and FVIII consumption for patients with moderate to severe Haemophilia A.Guy Young, Michael U Callaghan, Vinod Balasa
|Oct 26, 2022
Safety of FEIBA and emicizumab (SAFE): Dose escalation study evaluating the safety of in vivo administration of activated prothrombin complex concentrate in haemophilia A patients on emicizumab.Hande Kizilocak, Elizabeth Marquez-Casas, Jemily Malvar
|Dec 28, 2021
Markers of hypercoagulability in children with newly diagnosed acute lymphoblastic leukemia.Roxana Carmona, Hande Kizilocak, Elizabeth Marquez-Casas
|Jun 11, 2021
Determining the approximate factor VIII level of patients with severe haemophilia A on emicizumab using in vivo global haemostasis assays.Hande Kizilocak, Elizabeth Marquez-Casas, Jemily Malvar
|Nov 27, 2020
Comparison of bypassing agents in patients on emicizumab using global hemostasis assays.Hande Kizilocak, Elizabeth Marquez-Casas, Choo Phei Wee
|Jul 06, 2019
Management of perioperative hemostasis in a severe hemophilia A patient with inhibitors on emicizumab using global hemostasis assays.Hande Kizilocak, Clara Lana Yukhtman, Elizabeth Marquez-Casas
Pageof 2
